https://newsletter.glp1studio.com/p/semaglutide-gets-tested-on-kidneysGLP-1 Studioen2026-09-22T12:10:09+00:00Semaglutide gets tested on kidneys, cancer and a three way weight loss showdownhttps://newsletter.glp1studio.com/p/lillys-ceo-makes-his-case-for-medicareGLP-1 Studioen2026-09-22T12:10:07+00:00Lilly's CEO makes his case for Medicare to pay for GLP-1shttps://newsletter.glp1studio.com/p/new-drug-option-after-bariatric-surgeryGLP-1 Studioen2026-09-21T12:10:09+00:00A new drug option when weight-loss surgery does not go far enoughhttps://newsletter.glp1studio.com/p/novo-says-ozempic-supply-holds-steadyGLP-1 Studioen2026-09-21T12:10:06+00:00Novo says Ozempic supply holds steady across Canada